MTOR and cancer: The primary mechanism of radiation resistance in cancer cells is the activation of the phosphoinositide 3-kinase (PI3K)/thymoma viral proto-oncogene 1 (AKT)/ mammalian target of rapamycin (mTOR) pathway [7,8], and blocking this pathway has been observed to increase sensitivity to radiation and improve the effect of RT on tumor cells.